PBRM1 and renal cell carcinoma: Furthermore, the expression of multiple predefined immune-related profiles, including IFNγ response, IFNα response, Fcγ receptor signaling pathway, lymphocyte mediated immunity, leukocyte mediated immunity, and adaptive immune response was also reduced in tumors with PBRM1 mutations across all three RCC patient cohorts (Fig. 4b).